Cell line development – global market drivers, trends and its impact on improving biologics development from early phase to IND during the drug discovery process
Posted: 19 March 2019 | Aparajita Dubey - Associate Consultant at Prescient Healthcare Group | No comments yet
Cell line development is a major step for examining the efficiency of drug discovery, toxicity and in-vitro testing. It reduces time, effort and cost, which minimises the chance of research drugs failing at the clinical trial stage. This stage involves the production of recombinant proteins such as monoclonal antibodies, bi-specific monoclonal antibodies, growth factors, enzymes and the latest novel approach of developing immunotherapy for the treatment of cancer using a wide variety of expression systems.